Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03163667
Title CB-839 With Everolimus vs. Placebo With Everolimus in Patients With RCC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Calithera Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.